GLADUE; Ronald P.
Patent Applications and Registrations
Patent applications and USPTO patent grants for GLADUE; Ronald P..The latest application filed is for "binding molecules to the human ox40 receptor".
Company Profile
2.18.34
- GLADUE; Ronald P. - Stonington CT
- Gladue; Ronald P - Stonington CT
Patent Activity
| Patent | Date |
|---|---|
| Binding Molecules To The Human Ox40 Receptor App 20220002428 - MIN; Jing ; et al. | 2022-01-06 |
| Binding Molecules To The Human Ox40 Receptor App 20190135932 - MIN; Jing ; et al. | 2019-05-09 |
| Binding molecules to the human OX40 receptor Grant 10,196,452 - Min , et al. Fe | 2019-02-05 |
| Binding Molecules To The Human Ox40 Receptor App 20180057600 - MIN; Jing ; et al. | 2018-03-01 |
| Binding molecules to the human OX40 receptor Grant 9,840,562 - Min , et al. December 12, 2 | 2017-12-12 |
| Antibodies To Cd40 App 20160152713 - Bedian; Vahe ; et al. | 2016-06-02 |
| Nucleic acids encoding antibodies to CCR2 Grant 9,238,691 - Gladue , et al. January 19, 2 | 2016-01-19 |
| Binding Molecules To The Human Ox40 Receptor App 20150218279 - Min; Jing ; et al. | 2015-08-06 |
| Binding molecules to the human OX40 receptor Grant 9,028,824 - Min , et al. May 12, 2 | 2015-05-12 |
| Antibodies To Ccr2 App 20140342450 - Gladue; Ronald P. ; et al. | 2014-11-20 |
| Antibodies to CCR2 Grant 8,710,191 - Gladue , et al. April 29, 2 | 2014-04-29 |
| Antibodies that bind CD40 and methods of treating cancer and enhancing immune responses Grant 8,388,971 - Bedian , et al. March 5, 2 | 2013-03-05 |
| Antibodies To Cd40 App 20130024956 - Bedian; Vahe ; et al. | 2013-01-24 |
| Cd40 Antibody Formulation And Methods App 20120263732 - Gladue; Ronald P. ; et al. | 2012-10-18 |
| Binding Molecules To The Human Ox40 Receptor App 20120225086 - Min; Jing ; et al. | 2012-09-06 |
| Antibodies To Cd40 App 20120225014 - Bedian; Vahe ; et al. | 2012-09-06 |
| Binding molecules to the human OX40 receptor Grant 8,236,930 - Min , et al. August 7, 2 | 2012-08-07 |
| Antibodies To Ccr2 App 20110274696 - Gladue; Ronald P. ; et al. | 2011-11-10 |
| Binding Molecules To The Human Ox40 Receptor App 20110206681 - Min; Jing ; et al. | 2011-08-25 |
| Binding molecules to the human OX40 receptor Grant 7,960,515 - Min , et al. June 14, 2 | 2011-06-14 |
| Cd40 Antibody Formulation And Methods App 20110104182 - Gladue; Ronald P. ; et al. | 2011-05-05 |
| Antibodies To Cd40 App 20100098694 - Bedian; Vahe ; et al. | 2010-04-22 |
| Cd40 Antibody Formulation And Methods App 20090311254 - Gladue; Ronald P. ; et al. | 2009-12-17 |
| Nucleic acid molecules which encode antibodies that bind CD40 Grant 7,626,012 - Bedian , et al. December 1, 2 | 2009-12-01 |
| Antibodies that bind CD40 and methods of treating cancer and enhancing immune responses Grant 7,618,633 - Bedian , et al. November 17, 2 | 2009-11-17 |
| Binding Molecules To The Human Ox40 Receptor App 20090214560 - Min; Jing ; et al. | 2009-08-27 |
| Chemokine antagonists as treatment for obesity-related and metabolic syndrome-related conditions App 20090196823 - Cornelius; Peter ; et al. | 2009-08-06 |
| Antibodies to CD40 and methods of treating cancer and enhancing immune responses Grant 7,563,442 - Bedian , et al. July 21, 2 | 2009-07-21 |
| Antibodies to CD40 App 20090169563 - Bedian; Vahe ; et al. | 2009-07-02 |
| Antibodies to CD40 App 20090130715 - Bedian; Vahe ; et al. | 2009-05-21 |
| Methods of treating cancer and enhancing immune responses with antibodies that bind CD40 Grant 7,338,660 - Bedian , et al. March 4, 2 | 2008-03-04 |
| Antibodies to CD40 Grant 7,288,251 - Bedian , et al. October 30, 2 | 2007-10-30 |
| Antibodies to CD40 App 20070190051 - Bedian; Vahe ; et al. | 2007-08-16 |
| Antibodies to CD40 App 20060093600 - Bedian; Vahe ; et al. | 2006-05-04 |
| CD40 antibody formulation and methods App 20050136055 - Gladue, Ronald P. ; et al. | 2005-06-23 |
| Methods for the identification of compounds useful for the treatment of disease states mediated by prostaglandin D2 Grant 6,878,522 - Li , et al. April 12, 2 | 2005-04-12 |
| Methods of using sulfonic acid derivatives App 20040116441 - Brown, Matthew F. ; et al. | 2004-06-17 |
| Heteroaryl-hexanoic acid amide derivatives as immonomodulatory agents App 20040097554 - Brown, Matthew F. ; et al. | 2004-05-20 |
| Methods of using piperazine derivatives App 20040092529 - Blumberg, Laura C. ; et al. | 2004-05-13 |
| Methods of using CCR1 antagonists as immunomodulatory agents App 20040087571 - Brown, Matthew F. ; et al. | 2004-05-06 |
| Novel piperazine derivatives App 20040058932 - Blumberg, Laura C. ; et al. | 2004-03-25 |
| Methods for treating chronic obstructive pulmonary disease (COPD) App 20030232048 - Yang, Xiao-dong ; et al. | 2003-12-18 |
| Piperazine derivatives Grant 6,649,611 - Blumberg , et al. November 18, 2 | 2003-11-18 |
| Antibodies to CD40 App 20030211100 - Bedian, Vahe ; et al. | 2003-11-13 |
| Treatment of T-cell mediated diseases App 20020168358 - Gladue, Ronald P. ; et al. | 2002-11-14 |
| Bridged piperazine derivatives App 20020119961 - Blumberg, Laura C. ; et al. | 2002-08-29 |
| Novel piperazine derivatives App 20020107255 - Blumberg, Laura C. ; et al. | 2002-08-08 |
| Methods for the identification of compounds useful for the treatment of disease states medicated by prostaglandin D2 App 20020022218 - Li, Baiyong ; et al. | 2002-02-21 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 